SWKH News and Press, SWK Holdings Corporation From 12/06/19

BOONTON, N.J. , Dec. 6, 2019 /PRNewswire/ --  Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (SWKH.OB), congratulates Cara Therapeutics ...

The following slide deck was published by SWK Holdings Corporation in conjunction with this Read more ...

DALLAS , Nov. 21, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, announced today that Winston Black , Chief Executive Officer of SWK, has been named Chairman of the Company's Board of Directors...

SWK Holdings ( OTCQB:SWKH ): Q3 Non-GAAP EPS of $0.39; GAAP EPS of $0.32. Revenue of $6.35M (+8.0% Y/Y) Press Release More news on: SWK Holdings Corporation, Earnings news and commentary, Financial stocks news, ,

DALLAS , Nov. 18, 2019 /PRNewswire/ -- Corporate Highlights Acquired Enteris BioPharma, Inc. ("Enteris") a biotechnology company offering innovative formulation solutions utilizing its proprietary oral drug delivery technology, Peptelligence® Enteris to operate as an indepe...

DALLAS , Sept. 16, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, announced that CEO Winston Black will present at the Fall Investor Summit being held today in New York City . Details of SWK's prese...

DALLAS , Sept. 6, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, today announced that its Board of Directors has authorized the Company to repurchase up to an aggregate of $2.1 million of the Compa...

DALLAS , Sept. 3, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, announced today that the Company has submitted its formal application to list its common shares on the NASDAQ Capital Market. Concu...

SWK Holdings ( OTCQB:SWKH ) announced a strategic acquisition whereby SWK, acquired 100% of Enteris' equity from Victory Park Capital. More news on: SWK Holdings Corporation, Merger & acquisition news, Read more ...

DALLAS and BOONTON, N.J. , Aug. 27, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, and Enteris BioPharma, Inc.  ("Enteris"), a biotechnology company offering innovative formulation solutions uti...